Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications
Open Access
Abstract
In recent years, cancer immunotherapy research has made remarkable progress, completely transforming the cancer treatment landscapeKeywords
This publication has 18 references indexed in Scilit:
- Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapyPharmacology & Therapeutics, 2022
- Interactions between Dietary Micronutrients, Composition of the Microbiome and Efficacy of Immunotherapy in Cancer PatientsCancers, 2022
- Recent Advances in Bacteria-Based Cancer TreatmentCancers, 2022
- The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD2 Antibody Dinutuximab BetaCancers, 2022
- Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 InhibitorCancers, 2022
- Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?Cancers, 2022
- Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment ResistanceCancers, 2021
- Acquired Resistance to Immune Checkpoint Blockade TherapiesCancers, 2020
- Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapyPharmacology & Therapeutics, 2018
- Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade TherapyCancer Research, 2017